Tag: legal action
Friday, May 9 (09:30-12:30), Farma ter Verantwoording and AbbVie will meet at the Amsterdam District Court, Parnassusweg 280, 1076 AV Amsterdam (near Amsterdam Zuid...
The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira
Wilbert Bannenberg -
The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to...
The Pharmaceutical Accountability Foundation faces AbbVie in Court for the first time in its Humira pricing case
Rosalind Turkie -
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros
Rosalind Turkie -
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
Version 15 November 2023
About Adalimumab/Humira and pricing issues
AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the...
Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie
Rosalind Turkie -
Download the original (Dutch) here:
antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload
Download the English translation here:
Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload
The Pharmaceutical Accountability Foundation recently launched a court case against pharma-giant AbbVie for excessive pricing of blockbuster drug Humira (adalimumab). We received media attention...
On 27 January we hosted the second part of our webinar series The Power of Law.
This second part was dedicated to presenting our...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022